92PLow expression of miR-20a-5p predicts benefit to...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

92PLow expression of miR-20a-5p predicts benefit to bevacizumab in metastatic breast cancer patients treated within the TANIA trial

Gampenrieder, S.P.P., Rinnerthaler, G., Hackl, H., Steiner, M., Monzo Fuentes, C., Hufnagl, C., Hauser-Kronberger, C., Egle, A., Greil, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx363.008
Date:
September, 2017
File:
PDF, 49 KB
english, 2017
Conversion to is in progress
Conversion to is failed